Effectiveness of Cladribine Tablets in Participants With Highly-active Relapsing Multiple Sclerosis (CAMELOT-MS)

Conditions: Relapsing-Remitting Multiple Sclerosis

Sponsors: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany; Merck Serono Limited, an affiliate of Merck KGaA, Darmstadt, Germany

Completed